Dougherty; Joseph P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dougherty; Joseph P..The latest application filed is for "hiv-1 latency model for high throughput screening".

Company Profile

0.21.3

Dougherty; Joseph P. - Milford NJ
Dougherty; Joseph P. - Hampton NJ
Dougherty; Joseph P. - New York NY
Dougherty; Joseph P - Hampton NJ
Dougherty; Joseph P. - State College PA
Dougherty; Joseph P. - Madison WI
Dougherty; Joseph P. - Somerville MA
Dougherty; Joseph P. - Niles MI
Dougherty; Joseph P. - White Haven PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
HIV-1 latency model for high throughput screening Grant 9,017,935 - Dougherty , et al. April 28, 2	2015-04-28
Hiv-1 Latency Model For High Throughput Screening App 20130040385 - Dougherty; Joseph P. ; et al.	2013-02-14
HIV-1 latency model for high throughput screening Grant 8,247,167 - Dougherty , et al. August 21, 2	2012-08-21
Hiv-1 Latency Model For High Throughput Screening App 20090305227 - Dougherty; Joseph P. ; et al.	2009-12-10
Myeloid precursor cell useful for gene therapy and for modulation of immune responses Grant 7,198,909 - Ron , et al. April 3, 2	2007-04-03
Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant RE38,333 - Arimilli , et al. November 25, 2	2003-11-25
Inducible packaging cell lines for lentivirus vectors Grant 6,613,569 - Dougherty , et al. September 2, 2	2003-09-02
Method for producing anisotropic dielectric layer and devices including same Grant 6,376,393 - Newton , et al. April 23, 2	2002-04-23
Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 6,069,249 - Arimilli , et al. May 30, 2	2000-05-30
Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 6,043,230 - Arimilli , et al. March 28, 2	2000-03-28
Method for reduction of sinter temperatures of antiferroelectric, lead-based ceramics by use of lithium compound additions and capacitors made with such ceramics Grant 5,993,895 - Jang , et al. November 30, 1	1999-11-30
Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability Grant 5,977,089 - Arimilli , et al. November 2, 1	1999-11-02
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability Grant 5,922,695 - Arimilli , et al. July 13, 1	1999-07-13
Cardiac defibrillator with multi-phase ferroelectric/antiferroelectric capacitor Grant 5,728,138 - Dougherty , et al. March 17, 1	1998-03-17
Cardiac defibrillator with high energy storage antiferroelectric capacitor Grant 5,545,184 - Dougherty August 13, 1	1996-08-13
Metallization compositions for BI and PB-containing ceramic dielectrics Grant 5,391,223 - Dougherty , et al. February 21, 1	1995-02-21
Recombination resistant retroviral helper cell and products produced thereby Grant 5,124,263 - Temin , et al. June 23, 1	1992-06-23
Promoter deficient retroviral vector Grant 4,980,289 - Temin , et al. December 25, 1	1990-12-25
Method and kit involving displacement and rehybridization of labeled polynucleotide Grant 4,818,680 - Collins , et al. April 4, 1	1989-04-04
Displacement polynucleotide method and reagent complex employing labeled probe polynucleotide Grant 4,752,566 - Collins , et al. June 21, 1	1988-06-21
Piezoelectric fluid pumping apparatus Grant 4,708,600 - AbuJudom, II , et al. November 24, 1	1987-11-24
Portable TV transmitter Grant 4,504,861 - Dougherty March 12, 1	1985-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.